RedCloud Bio is backed by leading healthcare investors.
July 2018 - RedCloud Bio raised a seed round funding with Sherpa Healthcare Partners and Dynamic Balance Investment Management.
November 2019 - The Company received Series A financing from Dayou
Capital and Sherpa Healthcare Partners.
June 2021 - RedCloud Bio secured investment of RMB 100 million in a
Series B financing led by Co-Win Ventures, participated by Kaitai Capital, Sherpa
Healthcare Partners, Dayou Capital and Dynamic Balance Investment Management.